Growth Metrics

Bio-Techne (TECH) Operating Leases (2019 - 2025)

Historic Operating Leases for Bio-Techne (TECH) over the last 7 years, with Q4 2025 value amounting to $77.2 million.

  • Bio-Techne's Operating Leases fell 542.91% to $77.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $77.2 million, marking a year-over-year decrease of 542.91%. This contributed to the annual value of $84.0 million for FY2025, which is 417.49% down from last year.
  • As of Q4 2025, Bio-Techne's Operating Leases stood at $77.2 million, which was down 542.91% from $80.7 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Operating Leases ranged from a high of $97.3 million in Q3 2023 and a low of $56.3 million during Q1 2022
  • Moreover, its 5-year median value for Operating Leases was $80.1 million (2025), whereas its average is $78.2 million.
  • In the last 5 years, Bio-Techne's Operating Leases tumbled by 1566.69% in 2022 and then surged by 6551.96% in 2023.
  • Over the past 5 years, Bio-Techne's Operating Leases (Quarter) stood at $57.7 million in 2021, then soared by 35.46% to $78.2 million in 2022, then increased by 22.82% to $96.0 million in 2023, then dropped by 15.01% to $81.6 million in 2024, then dropped by 5.43% to $77.2 million in 2025.
  • Its Operating Leases was $77.2 million in Q4 2025, compared to $80.7 million in Q3 2025 and $84.0 million in Q2 2025.